Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Efficacy and safety of switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) in virologically suppressed women
- Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older
- Alirocumab vs usual lipid-lowering care as add?on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
- Survival outcomes for advanced kidney cancer patients in the era of targeted therapies
- Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
PHARMACOLOGY
- Clinical acceptability of trimetazidine modified-release 80 mg once daily vs trimetazidine modified-release 35 mg twice daily in stable angina pectoris
- Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia
- Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis
- Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia
- Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure
CLINICAL PHARMACOLOGY
- A phase II study to prevent radiation-induced rectal injury with lovastatin
- Dermatofibrosarcoma Protuberans: A Retrospective Study of Clinicopathological Features and Related Akt/mTOR, STAT3, ERK, Cyclin D1, and PD-L1 Expression
- Assessing venous thrombus in renal cell carcinoma: Preliminary results for unenhanced 3D-SSFP MRI
- Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing
- Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma
ONCOLOGY